Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (20)

2024

  1. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

    The Lancet Microbe, Vol. 5, Núm. 1, pp. e43-e51

2023

  1. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

  2. Tracking the Emergence and Dissemination of a blaNDM-23 Gene in a Multidrug Resistance Plasmid of Klebsiella pneumoniae

    Microbiology spectrum, Vol. 11, Núm. 2, pp. e0258522

2022

  1. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 279-284

  2. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3776-3782

  3. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection

    Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223

2021

  1. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. Nucleosome-specific, time-dependent changes in histone modifications during activation of the early growth response 1 (Egr1) gene

    Journal of Biological Chemistry, Vol. 290, Núm. 1, pp. 197-208

2010

  1. Evolution in the management of acute myocardial infarction in the autonomous community of Valencia (Spain): Ten years of the primvac registry (1995-2004)

    International Journal of Biomedical Science, Vol. 6, Núm. 2, pp. 87-95

2009

  1. Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus

    Journal of Medical Virology, Vol. 81, Núm. 4, pp. 650-656

2008

  1. Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV)

    Virus Research, Vol. 131, Núm. 2, pp. 224-232

  2. Genetic variability in hepatitis C virus and its role in antiviral treatment response

    Journal of Viral Hepatitis, Vol. 15, Núm. 3, pp. 188-199

  3. Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin

    PLoS ONE, Vol. 3, Núm. 8

  4. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment

    Journal of Medical Virology, Vol. 80, Núm. 2, pp. 247-253

  5. Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response

    Journal of Viral Hepatitis, Vol. 15, Núm. 8, pp. 578-590

  6. Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus

    Infection, Genetics and Evolution, Vol. 8, Núm. 1, pp. 74-82

2007

  1. Contribution of insertions and deletions to the variability of hepatitis C virus populations

    Journal of General Virology, Vol. 88, Núm. 8, pp. 2198-2203

  2. Epidemic dynamics of two coexisting hepatitis C virus subtypes

    Journal of General Virology, Vol. 88, Núm. 1, pp. 123-133

2004

  1. Mortalidad del infarto de miocardio en el registro PRIMVAC. Factores pronósticos

    Medicina Clinica, Vol. 122, Núm. 15, pp. 561-565